FDA Authorizes Booster for Children Aged 5-11
Aiden Arthurs receives the Pfizer-BioNTech Covid-19 Vaccine from Pharmacist Andrew Mac (R) at the Jewish Federation/JARC's offices in Bloomfield Hills, Michigan, on May 13, 2021. - The US Food and Drug Administration (FDA) on May 10, 2021 authorized the use of the Pfizer-BioNTech Covid-19 vaccine for children aged 12 to 15 years old. (Photo by JEFF KOWALSKY / AFP) (Photo by JEFF KOWALSKY/AFP via Getty Images)
On Tuesday, the Food and Drug Administration authorized Pfizer-BioNTech booster shots for children ages 5 to 11.
Over 8 million children in that age group in the U.S. have received two shots of a Covid-19 vaccine.
Those children are now qualified to receive boosters five months after their second vaccine shots.
Only six percent of U.S. children in that age range have received just one vaccine.